The Duke Fellowship Training Programs in Pulmonary and Critical Care Medicine produce outstanding physicians who are fully prepared to pursue careers in academic medicine.
Our combined Pulmonary and Critical Care Medicine fellowship program is a three-year program. Upon completion of training, fellows are eligible for dual certification in pulmonary and critical care medicine. The American Board of Internal Medicine requires a minimum 18 months of clinical training for board certification in both of these disciplines. All fellows in our combined program engage in scholarly activity and receive robust mentorship from our world-renowned faculty. We offer a fourth year of fellowship for trainees seeking advanced research training.
Our combined fellowship program accepts 5 fellows each year.
In their words
See why our fellows chose Duke, the strengths of the Duke PCCM Fellowship Program, and more.
As you explore our programs, please visit our about Duke and Durham page to see all that our city has to offer. We also encourage you to check out our 48 hours in Durham list, which highlights some of our favorite things to do and places to visit in the area.
Latest News
Residency Match Day 2022 Results Announced
The Duke Internal Medicine Residency Program and the Duke Department of Medicine congratulate newly matched medical students who participated in the 2022 National Resident Matching Program. We are especially excited to welcome our newest intern class! We cannot wait for you to join us here in Durham.
The Mystery of Long COVID: Brain Fog, Fatigue, Even Sexual Dysfunction
By Steve Hartsoe
Thousands of COVID-19 survivors continue to grapple with symptoms many months after they were first infected. Brain fog, fatigue, even sexual dysfunction are among the symptoms people endure weeks and months after their acute COVID symptoms fade.
On some occasions, the virus reveals a pre-existing disease or causes another to inflict the patient.
But there is still much unknown about so-called long COVID, which ongoing research at Duke University and elsewhere aims to clarify.
Taylor Takes on New Role of Associate Vice Chair for Global Health Research
Steve M. Taylor, MD, MPH, associate professor of medicine, Division of Infectious Diseases, and associate research professor of global health, is taking on the new position of Associate Vice Chair for Global Health Research in the Department of Medicine effective March 1, 2022.
Robert M. Califf Confirmed as Commissioner for the US Food and Drug Administration
Robert M. Califf, MD, Duke University adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute (DCRI), has been confirmed as commissioner for the U.S. Food and Drug Administration following a vote by the Senate today. Califf’s appointment to the position will mark his second time heading the agency, which he also led during the final year of former President Barack Obama’s administration.
School of Medicine is Third in Nation for Federal Medical Research Funding
Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical centers, up from 10th last year, according to the Blue Ridge Institute for Medical Research.
The Department of Medicine's award of that total was $174,530,472.
Duke Researchers Play Key Role in NIH Cellular Senescence Database
A Duke research team will play a key role in mapping cellular senescence in lung tissue as part of an NIH initiative to create a foundational database to identify senescent biomarkers that signal the cessation of cell division.
The $12.7 million, five-year NIH grant to Duke is part of the Cellular Senescence Network (SenNet), a national consortium involving eight tissue mapping centers and 17 universities collaborating in an investigation into the triggers of senescence. The NIH Common Fund supports the SenNet project.
New funding awards - September 2021
Sponsored Research
Melissa Daubert of Cardiology has received an award from the National Institutes of Health for a project entitled "Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study." Total funding will be $7,892,380.
Pearls from 10/12/21 Medicine LEADS
The October 12, 2021, session of Duke Medicine LEADS featured Adam DeVore, MD; Omar Mohamedaly, MD; Stephen J. Greene, MD; and Lindsay King, MD, presenting "Perspectives and Innovations in Multidisciplinary Care at Duke."
Faculty promotions appoved by Board of Trustees - August and September 2021
Congratulations to the following faculty members for their recent promotion in the Department of Medicine. The following changes were approved during the August 20, 2021, and September 24, 2021, Board of Trustees meetings.